| Sumario: | Rosacea is a chronic and sometimes progressive inflammatory dermatosis, characterised by flare-ups and remissions, typically presenting with facial symptoms and known to adversely affect patients' quality of life. Making the correct diagnosis and selecting the most appropriate treatment is essential to ensure effective outcomes for the patient with rosacea. Evidence-based practice (EBP) is an approach to decision-making in which the clinician uses the best evidence available to decide, in partnership with the patient, on the option that best suits that patient (Gray, 1997). This requires Healthcare Professionals (HCPs) to find, appraise and use the most current and valid research findings. This is essential to review the clinical evidence for efficacy and safety before implementing a management plan that demonstrates patient-centred care. Cochrane Reviews are systematic reviews of primary research in human health care and health policy, and are internationally recognised as the highest standard in evidence-based health care. This article discusses latest findings and recommendations for the treatment and management of rosacea from the Cochrane review into treatments for Rosacea, 2011.
|
|---|